Amidi Pharmaceuticals Private Limited
About Amidi Pharmaceuticals Private Limited
Data last updated:
Amidi Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 22 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24299BR2021PTC053057. Its GSTIN is 10AAVCA5255B1ZZ (Bihar).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sachin Singh and Anjani Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C/O Anju Devi Munna Chak Near Nobel Engineering Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2022, the company reported a revenue of ₹61,717. For the same year it recorded a net loss of ₹13,056 (net margin -21.2%) and EBITDA of -₹13,056 (EBITDA margin -21.2%).
Company details
Contact details
Amidi Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Anju Devi Munna Chak Near Nobel Engineering Kankarbagh, Patna, Bihar, India – 800020
- IndustryChemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
To see the full contact details of Amidi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Amidi Pharmaceuticals Private Limited
FY 2022 filings availableAmidi Pharmaceuticals Private Limited reported revenue of ₹61,717 for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹61,717 |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹13,056 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹13,056 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | -21.2% |
| Net Profit Margin | -21.2% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Amidi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amidi Pharmaceuticals Private Limited
Amidi Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Singh Also directs: New Chanarika Hospital Private Limited | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
| Anjani Kumar | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Amidi Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pushkar Pharmaceuticals Pvt Ltd | ₹63,000 (FY 2024) | 23.0% | Chandigarh, India | |||
| Mankem Pharmaceuticals Private Limited | ₹62,976 (FY 2025) | -20.0% | Jehanabad, Bihar, India | |||
| Lasis Pharmaceuticals Private Limited | ₹62,451 (FY 2025) | 217.0% | Darbhanga, Bihar, India | |||
| Dalam Pharmaceuticals Private Limited | ₹62,450 (FY 2024) | -48.0% | Karimnagar, Telangana, India | |||
| Emsons Pharmaceuticals Pvt Ltd | ₹62,450 (FY 2020) | 13.0% | Kolkata, West Bengal, India | |||
| Amidi Pharmaceuticals Private Limitedthis company | ₹61,717 (FY 2022) | -₹13,056 | -21.2% | Patna, Bihar, India | ||
| Halcyon Pharmaceuticals Limited | ₹61,632 (FY 2024) | -33.0% | Hisar, Haryana, India | |||
| Enmando Pharmaceuticals Private Limited | ₹61,500 (FY 2024) | -50.0% | Saidulajab, Delhi, India | |||
| Sannolik Pharmaceuticals Private Limited | ₹60,500 (FY 2023) | -69.0% | Gaya, Bihar, India | |||
| Mitosis Pharmaceuticals Private Limited | ₹59,685 (FY 2025) | 186.0% | Govind Nagar, Uttar Pradesh, India | |||
| Nubiotic Pharmaceuticals Private Limited | ₹59,207 (FY 2021) | -57.0% | Patna, Bihar, India |
To see the full peer comparison of Amidi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amidi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amidi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amidi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAVCA5255B1ZZ | Bihar | Active | 29 Sep 2021 |
To see the full GST registrations and return filing status of Amidi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amidi Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anjani Kumar was appointed as Director on 22 Jul 2021.
Frequently asked questions
Amidi Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 22 July 2021 (5+ years old) and is registered under CIN U24299BR2021PTC053057.
Amidi Pharmaceuticals has 2 current directors:
- Sachin Singh - Director
- Anjani Kumar - Director
The latest financial statements of Amidi Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Amidi Pharmaceuticals is 10AAVCA5255B1ZZ, registered in Bihar.
The CIN (Corporate Identification Number) of Amidi Pharmaceuticals is U24299BR2021PTC053057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amidi Pharmaceuticals was incorporated on 22 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Amidi Pharmaceuticals by revenue are Pushkar Pharmaceuticals Pvt Ltd, Mankem Pharmaceuticals Private Limited, Lasis Pharmaceuticals Private Limited, Dalam Pharmaceuticals Private Limited, Emsons Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Pharmaceuticals).
Anjani Kumar was appointed as Director on 22 Jul 2021. Sachin Singh was appointed as Director on 22 Jul 2021.
The registered office of Amidi Pharmaceuticals is at CO Anju Devi Munna Chak Near Nobel Engineering Kankarbagh, Patna, Bihar, India – 800020.
Amidi Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Amidi Pharmaceuticals can be reached at its registered office: CO Anju Devi Munna Chak Near Nobel Engineering Kankarbagh, Patna, Bihar, India – 800020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
